The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1333
Hyperbaric Oxygen Therapy for Refractory Wounds
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.

Hyperbaric oxygen (HBO2) therapy, breathing 100% O2 while exposed to increased atmospheric pressure, has been used for years to treat refractory wounds, especially diabetic foot ulcers.1

MECHANISM OF ACTION — HBO2 raises hydrostatic pressure and the partial pressure of O2. Increasing hydrostatic pressure causes a reduction in the volume of gas-filled spaces and prevents downstream vasoconstriction. Increasing oxygen partial pressures in body fluids increases oxygenation of tissues. HBO2 also reduces circulating levels of pro-inflammatory cytokines, increases synthesis of vascular endothelial growth factor (VEGF) and proliferation of fibroblasts, stimulates angiogenesis, and mobilizes stem/progenitor cells that accelerate healing.2,3

CLINICAL STUDIES — HBO2 is used in current practice mainly ... more      

The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Hyperbaric Oxygen Therapy for Refractory Wounds
Article code: 1333c
 Electronic, downloadable article - $45
Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.
Recommend to your librarian